Td Waterhouse Canada Inc. Can Fite Bio Pharma Ltd. Transaction History

Td Waterhouse Canada Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 Nov 13, 2023	SELL	$0.55 - $6.57 $111 - $1,333	-203 Closed	0 $0
Q4 2021 Nov 13, 2023	BUY	$0.98 - $2.15 $198 - $436	203 New	203 $354,000

1.1K

Ticker CANF
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,191,500
Market Cap $53.3M
Description
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinic...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.